Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
46.39
+0.08 (0.16%)
May 5, 2026, 9:32 AM EDT - Market open
GNOM Holdings Information
GNOM is an equity ETF with a total of 50 individual holdings. The top holdings are Arrowhead Pharmaceuticals stock at 7.36%, Moderna at 7.28%, Praxis Precision Medicines at 6.56%, Illumina at 5.66%, and Guardant Health at 4.80%.
Total Holdings
50
Top 10 Percentage
51.34%
Asset Class
Equity
ETF Category
Health
Assets
51.08M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.36% |
| 2 | MRNA | Moderna, Inc. | 7.28% |
| 3 | PRAX | Praxis Precision Medicines, Inc. | 6.56% |
| 4 | ILMN | Illumina, Inc. | 5.66% |
| 5 | GH | Guardant Health, Inc. | 4.80% |
| 6 | NTRA | Natera, Inc. | 4.26% |
| 7 | BMRN | BioMarin Pharmaceutical Inc. | 4.13% |
| 8 | VRTX | Vertex Pharmaceuticals Incorporated | 4.03% |
| 9 | BNTX | BioNTech SE | 3.74% |
| 10 | TECH | Bio-Techne Corporation | 3.52% |
| 11 | CRSP | CRISPR Therapeutics AG | 3.27% |
| 12 | TWST | Twist Bioscience Corporation | 3.23% |
| 13 | LEGN | Legend Biotech Corporation | 2.91% |
| 14 | QGEN | Qiagen N.V. | 2.73% |
| 15 | BMY | Bristol-Myers Squibb Company | 2.71% |
| 16 | BEAM | Beam Therapeutics Inc. | 2.60% |
| 17 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.44% |
| 18 | VCYT | Veracyte, Inc. | 2.36% |
| 19 | LLY | Eli Lilly and Company | 2.35% |
| 20 | TXG | 10x Genomics, Inc. | 2.30% |
| 21 | GILD | Gilead Sciences, Inc. | 2.20% |
| 22 | LON: AZN | AstraZeneca PLC | 2.19% |
| 23 | RARE | Ultragenyx Pharmaceutical Inc. | 2.06% |
| 24 | SRPT | Sarepta Therapeutics, Inc. | 1.84% |
| 25 | HKG: 1548 | Genscript Biotech Corporation | 1.82% |
As of May 1, 2026